B. Braun 26-Lead Transfer Set Recall: Incorrect Valve Orientation Risk
B. Braun recalls 26-Lead Transfer Sets for APEX Compounding System with potential for incorrect valve orientation causing unintended drug mixtures. Check product catalog numbers listed.
Lower-risk recall
There is a potential for valves on the 26-Lead Transfer Set to be incorrectly oriented. When a transfer set with an incorrectly oriented valve is installed on the system, there is potential for unintended admixture.
Contact the company
What happened, in plain English
B. Braun is recalling 26-Lead Transfer Sets used with APEX Compounding Systems due to a risk of valves being incorrectly oriented. This could lead to unintended drug mixtures if the transfer set is installed improperly. Read more at govinfonow.com/recall/70907-b-braun-26-lead-transfer-set-recall-incorrect-valve-orientation.
Source Summary by GovInfoNow · govinfonow.com/recall/70907-b-braun-26-lead-transfer-set-recall-incorrect-valve-orientation · Updated August 21, 2026 · FDA enforcement record: FDA #Z-2343-2018
Cite this page
“B. Braun 26-Lead Transfer Set Recall: Incorrect Valve Orientation Risk.” GovInfoNow, updated August 21, 2026. https://govinfonow.com/recall/70907-b-braun-26-lead-transfer-set-recall-incorrect-valve-orientation. Based on FDA recall #Z-2343-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2343-2018%22&limit=1).
Why it’s dangerous
The transfer set's valves may be installed incorrectly, which can cause unintended mixing of medications. This risk occurs when the transfer set is attached to the APEX Compounding System without proper valve alignment.
Who’s affected
Healthcare professionals using the APEX Compounding System with the recalled transfer sets are most at risk. Patients receiving compounded medications through these systems may be affected if the transfer set is incorrectly installed.
How to tell if you have this one
Check for product catalog numbers: 0061546906, 0061546910, 0061548145, and other numbers listed in the recall notice. These sets were sold with the APEX Compounding System.
- Brand
B. Braun- Category
Medical device
What to do — step by step
Check Valve Orientation
Inspect the transfer set for correct valve alignment before installation on the APEX Compounding System.
Where it went and when
Where it was distributed
Distributed in 20 states.
FDA distribution: “The products were distributed to the following US states: AL, CA, CO, CT, FL, GA, IL, LA, MA, MD, MI, MN, MO, NC, NJ, NV, OH, PA, TX, and WA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, California, Colorado, Connecticut, Florida, Georgia, Illinois, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nevada, New Jersey, North Carolina, Ohio, Pennsylvania, Texas, Washington.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Do I need to stop using the product?
The recall does not require immediate discontinuation; users should check valve orientation before installation.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-2343-2018 (June 4, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2343-2018 to see it in context.
- Plain-language summary written by qwen3:4b on August 21, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.